Overview

  • Product nameCPPG
  • Description
    Potent group II/III metabotropic glutamate receptor antagonist
  • Biological descriptionPotent group II/III metabotropic glutamate receptor antagonist. Displays 20-fold selectivity for Group III over Group II. Ki values are 11.5, 17.3 and 4.02 μM for mGlu receptor subtypes mGlu6 mGlu7a and mGlu8a, respectively.
  • Purity> 99%

Properties

    References for CPPG (ab120775)

    This product has been referenced in:
    • Wright RA  et al. Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 362:546-54 (2000). Read more (PubMed: 11138847) »
    • Toms NJ  et al. The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. Br J Pharmacol 119:851-4 (1996). Read more (PubMed: 8922731) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120775.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"